ANI Pharmaceuticals (BSFA) Q1 2026 Earnings Report
CH:BSFA Q1 2026 EPS Results
- Actual EPS
- CHF 1.69
- Consensus EPS
- CHF 1.07
- Beat/Miss
- Beat by +CHF 0.62
- One Year Ago EPS
- CHF 1.40
CH:BSFA Q1 2026 Revenue Results
- Actual Revenue
- CHF 195.86M
- Expected Revenue
- CHF 171.25M
- Beat/Miss
- Beat by +CHF 24.61M
- YoY Revenue Growth
- +20.46%
Earnings Announcement Details
- Quarter
- Q1 2026
- Date
- 05/08/2026
- Time
- Before Open
- Conference Call
- Friday, May 8, 2026
CH:BSFA Upcoming Earnings
ANI Pharmaceuticals's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q1 2026 Earnings Call Audio
CH:BSFA Q1 2026 Earnings Call
0:00 / 0:00
Q1 2026 Earnings Slide Deck
Q1 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:BSFA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | 1.80- | 1.68 | ― | ― |
| Aug 07, 2026 | 2026 (Q2) | 1.691.82 | 1.48 | 22.78% (+0.34) | |
| May 08, 2026 | 2026 (Q1) | 1.071.69 | 1.4 | 20.59% (+0.29) | |
| Mar 03, 2026 | 2025 (Q4) | 1.641.92 | 1.34 | 42.94% (+0.58) | |
| Nov 10, 2025 | 2025 (Q3) | 1.461.68 | 1.11 | 52.24% (+0.58) | |
| Aug 08, 2025 | 2025 (Q2) | 1.161.48 | 0.84 | 76.47% (+0.64) | |
| May 09, 2025 | 2025 (Q1) | 1.141.40 | 1 | 40.50% (+0.40) | |
| Feb 28, 2025 | 2024 (Q4) | 1.181.34 | 0.82 | 63.00% (+0.52) | |
| Nov 08, 2024 | 2024 (Q3) | 0.901.11 | 1.05 | 5.51% (+0.06) | |
| Aug 06, 2024 | 2024 (Q2) | 0.780.84 | 1.06 | -20.31% (-0.21) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
